Provided by Tiger Trade Technology Pte. Ltd.

Acumen Pharmaceuticals, Inc.

2.63
+0.04001.54%
Volume:426.34K
Turnover:1.14M
Market Cap:159.31M
PE:-1.19
High:2.78
Open:2.66
Low:2.60
Close:2.59
52wk High:3.60
52wk Low:0.8551
Shares:60.57M
Float Shares:32.93M
Volume Ratio:0.75
T/O Rate:1.29%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.2064
EPS(LYR):-1.7051
ROE:-85.93%
ROA:-42.23%
PB:1.71
PE(LYR):-1.54

Loading ...

Jan 05, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 05, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 12, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 12, 2025

Major Issues Report

Form 8-K - Current report
Nov 10, 2025

Major Issues Report

Form 8-K - Current report
Aug 12, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 12, 2025

Major Issues Report

Form 8-K - Current report
Jul 15, 2025

Major Issues Report

Form 8-K - Current report
Jun 05, 2025

Major Issues Report

Form 8-K - Current report
May 13, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 13, 2025

Major Issues Report

Form 8-K - Current report
Mar 27, 2025

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Mar 27, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 27, 2025

Major Issues Report

Form 8-K - Current report
Jan 23, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 21, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 21, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 21, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 21, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 21, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities